These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29061982)

  • 1. The role of EZH2 in overall survival of colorectal cancer: a meta-analysis.
    Vilorio-Marqués L; Martín V; Diez-Tascón C; González-Sevilla MF; Fernández-Villa T; Honrado E; Davila-Batista V; Molina AJ
    Sci Rep; 2017 Oct; 7(1):13806. PubMed ID: 29061982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of EZH2 expression in patients with oesophageal cancer: a meta-analysis.
    Wang Y; Gao F; Zhao M; Li B; Xing D; Wang J; Yang Y
    J Cell Mol Med; 2016 May; 20(5):836-41. PubMed ID: 26859127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of EZH2 expression in patients with digestive cancers: a meta-analysis.
    Wang W; Wang F; Zong G; Liu R; Zhang Y; Luan Y; Xu L; Xuan J
    Int J Clin Exp Med; 2015; 8(9):16043-9. PubMed ID: 26629110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of EZH2 Expression in Non-Small Cell Lung Cancer: A Meta-analysis.
    Wang X; Zhao H; Lv L; Bao L; Wang X; Han S
    Sci Rep; 2016 Jan; 6():19239. PubMed ID: 26754405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway.
    Kurihara H; Maruyama R; Ishiguro K; Kanno S; Yamamoto I; Ishigami K; Mitsuhashi K; Igarashi H; Ito M; Tanuma T; Sukawa Y; Okita K; Hasegawa T; Imai K; Yamamoto H; Shinomura Y; Nosho K
    Oncotarget; 2016 Mar; 7(11):12704-17. PubMed ID: 26871294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of enhancer of zeste homologue 2 (EZH2) at tumor invasion front is correlated with higher aggressiveness in colorectal cancer cells.
    Böhm J; Muenzner JK; Caliskan A; Ndreshkjana B; Erlenbach-Wünsch K; Merkel S; Croner R; Rau TT; Geppert CI; Hartmann A; Roehe AV; Schneider-Stock R
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2227-2240. PubMed ID: 31317325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EZH2 expression is a prognostic biomarker in patients with colorectal cancer treated with anti-EGFR therapeutics.
    Yamamoto I; Nosho K; Kanno S; Igarashi H; Kurihara H; Ishigami K; Ishiguro K; Mitsuhashi K; Maruyama R; Koide H; Okuda H; Hasegawa T; Sukawa Y; Okita K; Takemasa I; Yamamoto H; Shinomura Y; Nakase H
    Oncotarget; 2017 Mar; 8(11):17810-17818. PubMed ID: 28147317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EZH2 overexpression is associated with poor prognosis in patients with glioma.
    Zhang Y; Yu X; Chen L; Zhang Z; Feng S
    Oncotarget; 2017 Jan; 8(1):565-573. PubMed ID: 27880940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of EZH2 protein expression in gastric carcinogenesis among Asians: a meta-analysis.
    Guo L; Yang TF; Liang SC; Guo JX; Wang Q
    Tumour Biol; 2014 Jul; 35(7):6649-56. PubMed ID: 24705718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis.
    Fluge Ø; Gravdal K; Carlsen E; Vonen B; Kjellevold K; Refsum S; Lilleng R; Eide TJ; Halvorsen TB; Tveit KM; Otte AP; Akslen LA; Dahl O;
    Br J Cancer; 2009 Oct; 101(8):1282-9. PubMed ID: 19773751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
    Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
    Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of COX-2 immunohistochemical expression in colorectal cancer: a meta-analysis of the literature.
    Peng L; Zhou Y; Wang Y; Mou H; Zhao Q
    PLoS One; 2013; 8(3):e58891. PubMed ID: 23527044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma.
    Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T
    Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SUMOylation of E2F1 Regulates Expression of EZH2.
    Du L; Fakih MG; Rosen ST; Chen Y
    Cancer Res; 2020 Oct; 80(19):4212-4223. PubMed ID: 32816857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of enhancer of zeste homolog 2 mutations on the prognosis of patients with myelodysplastic syndrome: A meta-analysis.
    Huang X; Wang X
    Medicine (Baltimore); 2020 Aug; 99(34):e21900. PubMed ID: 32846854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer of Zeste Homolog 2 in Colorectal Cancer Development and Progression.
    Bremer SCB; Conradi LC; Mechie NC; Amanzada A; Mavropoulou E; Kitz J; Ghadimi M; Ellenrieder V; Ströbel P; Hessmann E; Gaedcke J; Bohnenberger H
    Digestion; 2021; 102(2):227-235. PubMed ID: 31694013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of EZH2 and DNA methylation in the silencing of the tumour suppressor RUNX3 in colorectal cancer.
    Kodach LL; Jacobs RJ; Heijmans J; van Noesel CJ; Langers AM; Verspaget HW; Hommes DW; Offerhaus GJ; van den Brink GR; Hardwick JC
    Carcinogenesis; 2010 Sep; 31(9):1567-75. PubMed ID: 20631058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation, migration, and invasion in endometrial cancer cell lines.
    Eskander RN; Ji T; Huynh B; Wardeh R; Randall LM; Hoang B
    Int J Gynecol Cancer; 2013 Jul; 23(6):997-1005. PubMed ID: 23792601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and clinicopathological significance of EED, SUZ12 and EZH2 mRNA in colorectal cancer.
    Liu YL; Gao X; Jiang Y; Zhang G; Sun ZC; Cui BB; Yang YM
    J Cancer Res Clin Oncol; 2015 Apr; 141(4):661-9. PubMed ID: 25326896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Value of EZH2 in Non-Small-Cell Lung Cancers: A Meta-Analysis and Bioinformatics Analysis.
    Fan K; Zhang CL; Qi YF; Dai X; Birling Y; Tan ZF; Cao F
    Biomed Res Int; 2020; 2020():2380124. PubMed ID: 33299862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.